Elite Pharmaceuticals's total assets for Q2 2025 were $88.20M, an increase of 0.40% from the previous quarter. ELTP total liabilities were $40.93M for the fiscal quarter, a 38.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.